Moneo Ocaña, Victoria,García Fernández, Luis Francisco,Galmarini, Carlos María,Guillén Navarro, María José,Avilés Marín, Pablo Manuel,Santamaría Nuñez, Gema
申请号:
HRP20200696
公开号:
HRP20200696T1
申请日:
2020.04.30
申请国别(地区):
HR
年份:
2020
代理人:
摘要:
The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM001 04, and the use of these combinations in the treatment of cancer.